Wexford Capital LP Deciphera Pharmaceuticals, Inc. Transaction History

Wexford Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $457,696 - $670,532	-13,984 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $301,094 - $384,902	-5,816 Reduced 29.37%	13,984 $798,000
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $867,240 - $1.15 Million	19,800 New	19,800 $1.02 Million
Q2 2020 Aug 13, 2020	SELL	$37.05 - $65.03 $370,759 - $650,755	-10,007 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$33.63 - $69.4 $168,385 - $347,485	5,007 Added 100.14%	10,007 $412,000
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $158,500 - $349,650	5,000 New	5,000 $311,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.